DRKS00027840招募中不适用
Response prediction of neoadjuvant therapy in advanced pancreatic cancer (Neo-Response-Trial) - NeoResponse
Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie, Universitätsklinikum Carl Gustav Carus der TU Dresden0 个研究点目标入组 310 人开始时间: 2022年2月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 310
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Initial inclusion criteria
- •- High-grade suspicion of pancreatic tumor on imaging.
- •Specific inclusion criteria after staging/histologic confirmation:
- •- Histologically confirmed, irresectable or borderline resectable pancreatic ductal adenocarcinoma (cT3-4 cNx M0) according to NCCN guidelines or the consensus of the International Study Group of Pancreatic Cancer.
- •- Exclusion of distant metastases by imaging of thorax/abdomen
- •- Planned implementation of neoadjuvant systemic therapy
- •- No contraindication to resection of the primarius (general operability given)
- •- No contraindications to performing neoadjuvant systemic therapy
- •- Female and male patients = 18 years of age.
- •- ECOG score = 2
- •- Patient is able and willing to give written informed consent and comply with the study protocol.
排除标准
- •- Patients with recurrence (with or without previous incomplete/complete tumor resection)
- •- Patients with previous systemic tumor-specific therapy (such as chemotherapy or targeted therapy)
- •- Patients who are housed in a closed facility
研究者
相似试验
已完成
不适用
To assess response of tumor to chemotherapy given before surgery by using PET CT scan.CTRI/2014/07/004767ot Applicable75
尚未招募
不适用
Prediction of response to Neoadjuvant chemotherapy(bi-weeklyS1/Docetaxel therapy) in advanced gastric cancerGastric cancerJPRN-UMIN000011521Yokohama City University School of Medicine Department of Gastroenterological Surgery50
尚未招募
不适用
Predicting tumor response to neoadjuvant chemotherapy in esophageal cancer patients-correlation between hypoxic imaging and signal transduction pathwaysesophageal cancerJPRN-UMIN000045299Institute of Advanced Clinical Medicine, Kindai University40
终止
不适用
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast CancerBreast CancerNCT01007890Precision Therapeutics134
尚未招募
不适用
Preoperative identification of response to neoadjuvant chemoradiotherapy for esophageal cancer.Esophageal cancer.MRI. PET-CT.Oesofaguscarcinoom.Slokdarmkanker.NL-OMON24280niversity Medical Center Utrecht30